COVID-19

As scientific conferences return to in person programming, we still need COVID-19 precautions.

Microarray, or microneedle, patches could boost vaccine access in low- and middle-income countries.

What do zoonotic spillover events reveal about virus-host biology and how do scientists use these lessons to inform future mitigation strategies? 

Researchers investigate new approaches to revolutionizing vaccines for cancer and infectious diseases. 

COVID-19 researchers focus their studies on antibodies targeting exposed parts of SARS-CoV-2, but in a new study, a group of researchers showed that antibodies targeting proteins inside the virus are just as important for a robust immune response.

In the 21^st century, viral spillovers will become more and more common. We are not in the dark and can prepare now for new breakouts before they even begin.

Researchers around the world are on a mission to bank biological samples from millions of people. So far, these efforts have disclosed the effects of arsenic exposure on the genome, supported development of early cancer diagnostics, and even revealed the ideal timing for COVID-19 boosters.

CRISPR biosensing technology provides unambiguous pathogen detection.

Automated synthetic biology workflows enable efficient mRNA-based therapeutic development.

Advanced diagnostic devices hold potential for achieving precision healthcare.